Direct Flow Medical Transcatheter Aortic Valve System Demonstrates Excellent 30 Day Outcomes Following Full Enrollment of DISCOVER CE Mark Trial Results Presented in Oral Presentation at EuroPCR PARIS, France, May 22, 2013 – Direct Flow Medical®, Inc., a transcatheter...
Chimerix and BARDA Continue Collaboration on Development of CMX001 as a Medical Countermeasure Against Smallpox DURHAM, N.C., June 3, 2013 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of...
Concert Pharmaceuticals Initiates Phase 1 Clinical Trial of CTP-354, a Potential Treatment for Spasticity and Pain LEXINGTON, MA – June 10, 2013 – Concert Pharmaceuticals today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a...
Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion REDWOOD CITY, CALIF., June 10, 2013 – Pearl Therapeutics Inc. today announced that it has entered into a definitive merger agreement under which the Company will be acquired by AstraZeneca....
Recent Comments